The analysis showed a trend toward worse PFS for patients with ECOG > 2, but it did not reach statistical significance (HR = 1.74, 95% CI: 0.91–3.31; p = 0.09) ( Figure 4E ).
← all excerpts
A systematic evaluation of double-expressor lymphoma: prognostic impact, determinants of outcome, and comparative efficacy and safety of novel therapies.
1
—
—